MarketCap
Facebook
X
Telegram
Celcuity ROE Ratio | CELC
Annual ROE Ratio Celcuity
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -176.06 | -96.68 | -45.63 | -30.18 | -43.09 | -80.96 | -38.14 | -29.51 | -19.92 | - | - | - | - | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -19.92 | -176.06 | -62.24 |
Quarterly ROE Ratio Celcuity
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 566.68 | 430.18 | -288.88 | -232.84 | -213.85 | -196.3 | -107.72 | -81.19 | -62.97 | -62.88 | -62.7 | -56.23 | -51.4 | -56.62 | -62.1 | -65.31 | -66.48 | -49.54 | -82.72 | -77.77 | -89.74 | -99.62 | -61.6 | -66.49 | -54.06 | -45.67 | -39.46 | -34.37 | -32.38 | -29.96 | -30.05 | -22.31 | -27.8 | -25.8 | -24.29 | -19.67 | -73.17 | -5.66 | -3.15 | - | -58.99 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 566.68 | -288.88 | -43.12 |
ROE Ratio of other stocks in the Diagnostics research industry
| Issuer | ROE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M |  USA |
 |
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M |  Israel |
 |
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | USA |
 |
National Research Corporation
NRC
|
82.92 | $ 26.91 | 0.9 % | $ 602 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-16.42 | $ 132.17 | -2.35 % | $ 7.9 B | USA |
 |
Organovo Holdings
ONVO
|
1259.6 | - | -2.3 % | $ 19.4 M | USA |
 |
OpGen
OPGN
|
74.14 | - | -16.95 % | $ 1.54 M | USA |
 |
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | USA |
 |
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | USA |
 |
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | USA |
 |
Waters Corporation
WAT
|
25.09 | $ 476.29 | -0.09 % | $ 28.4 B | USA |
 |
Exagen
XGN
|
-114.34 | $ 5.26 | -25.92 % | $ 113 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 370.89 | -0.25 % | $ 30.9 B | USA |
 |
Lantheus Holdings
LNTH
|
21.43 | $ 101.65 | 0.63 % | $ 6.86 B | USA |
 |
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
98.27 | $ 664.97 | -1.18 % | $ 19.2 B | USA |
 |
Charles River Laboratories International
CRL
|
-4.56 | $ 346.21 | -2.02 % | $ 17.2 B | USA |
 |
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 750.2 | -0.69 % | $ 36.1 B |  Schweiz |
 |
Danaher Corporation
DHR
|
6.88 | $ 236.19 | 0.46 % | $ 168 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
8.16 | $ 30.39 | -1.32 % | $ 28.8 B |  Niderland |
 |
RadNet
RDNT
|
-1.71 | $ 77.91 | -0.6 % | $ 5.86 B | USA |
 |
Senseonics Holdings
SENS
|
-113.19 | $ 10.05 | 2.55 % | $ 419 M | USA |
 |
Neuronetics
STIM
|
-174.27 | $ 2.01 | -7.8 % | $ 133 M | USA |
 |
T2 Biosystems
TTOO
|
178.62 | - | -39.35 % | $ 313 K | USA |
 |
Thermo Fisher Scientific
TMO
|
12.58 | $ 719.09 | -0.35 % | $ 271 B | USA |
 |
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
419.21 | $ 155.43 | -2.12 % | $ 19.5 B | USA |
 |
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
4.69 | $ 10.63 | -8.68 % | $ 361 M | Israel |
 |
VolitionRx Limited
VNRX
|
68.2 | $ 0.19 | -6.2 % | $ 23.9 M |  Singapore |
 |
Natera
NTRA
|
-12.16 | $ 311.81 | -1.92 % | $ 42.6 B | USA |
 |
IQVIA Holdings
IQV
|
20.91 | $ 275.46 | -1.21 % | $ 47.4 B | USA |
 |
Agilent Technologies
A
|
19.33 | $ 178.84 | -0.74 % | $ 50.8 B | USA |
 |
Quotient Limited
QTNT
|
86.84 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | USA |
 |
Surmodics
SRDX
|
-9.71 | - | - | $ 608 M | USA |
 |
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | USA |
 |
Syneos Health
SYNH
|
7.63 | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | Israel |
 |
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | USA |
 |
Renalytix AI plc
RNLX
|
425.97 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Psychemedics Corporation
PMD
|
-36.28 | - | -1.84 % | $ 15.3 M | USA |
 |
Meridian Bioscience
VIVO
|
11.54 | - | - | $ 1.49 B | USA |
 |
DexCom
DXCM
|
30.46 | $ 79.92 | -1.42 % | $ 31.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 258.38 | -0.5 % | $ 28.7 B | USA |
 |
Castle Biosciences
CSTL
|
-5.13 | $ 34.41 | 0.07 % | $ 997 M | USA |
 |
IDEXX Laboratories
IDXX
|
65.99 | $ 696.77 | -1.4 % | $ 56 B | USA |